DCN and breast carcinoma: Since we identified EO cells in the tumor-bearing bones of human patients with metastatic breast cancer, and since EO cells express altered the amounts of NOV and decorin, which, in part, mediate breast cancer cell proliferation, we sought to assess the expression of NOV and decorin in human patient bone samples from individuals with bone metastatic breast cancer.